Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MND-SMART
NCT04302870Phase 3Recruiting
- Sponsor
- University of Edinburgh
- Start
- Feb 2020
- Primary completion
- Dec 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of memantine, trazodone hydrochloride prolonged-release tablets, amantadine, tacrolimus + Wuzhi capsule in motor neuron disease (MND), amyotrophic lateral sclerosis (ALS), sponsored by University of Edinburgh. Started Feb 2020; status: recruiting.
02
Drugs
memantinetrazodone hydrochloride prolonged-release tabletsamantadinetacrolimus + Wuzhi capsule
03
Conditions
motor neuron disease (MND)amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04302870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302870.